Skip to Main Content

Author Details

Nihal El Rouby
Department of Pharmacy Practice and Administrative Sciences, University of Cincinnati
2013
29
12
PMIDPaper TitleJournal TitlePublished Year
34729928Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.Clin Transl Sci2022
35488487A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.Clin Transl Sci2022
32770672Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.Clin Pharmacol Ther2021
34776967Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans.Front Pharmacol2021
34231218Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.Clin Pharmacol Ther2021
33428770Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Clin Pharmacol Ther2021
32860733Multi-site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos.Clin Transl Sci2021
31560448Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure.Clin Transl Sci2020
31758664Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention.Clin Transl Sci2020
33315113Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.JAMA Netw Open2020
33067866Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.CPT Pharmacometrics Syst Pharmacol2020
32747766Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.Genet Med2020
32678355Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection.Genet Med2020
30758238Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping Panel.Genet Test Mol Biomarkers2019
30237584Genome-wide association analysis of common genetic variants of resistant hypertension.Pharmacogenomics J2019
31319681Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.Ann Pharmacother2019
31423876Genome-Wide Meta-Analysis of Blood Pressure Response to β<sub>1</sub>-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).J Am Heart Assoc2019
31090079β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.J Clin Pharmacol2019
31033190Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans.Clin Transl Sci2019
29620484Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.Expert Opin Drug Metab Toxicol2018
29650764Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).Circ Genom Precis Med2018
28100040Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.Stem Cells2017
28222112Genome-wide study of resistant hypertension identified from electronic health records.PLoS One2017
26198781Genetics of resistant hypertension: a novel pharmacogenomics phenotype.Curr Hypertens Rep2015
26425837PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.J Hypertens2015
26494780Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.Stem Cells Transl Med2015
24945780The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.Pharmacogenet Genomics2014
25385345Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.J Am Heart Assoc2014
24116192Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.PLoS One2013
  • 1 - 29 of 29

Recommended Authors

Emily J Cicali
Department of Pharmacotherapy and Translational Research, University of Florida
Career Start Year 2019
Number of shared co-authors 13
Karla Claudio-Campos
University of Florida College of Medicine
Career Start Year 2015
Number of shared co-authors 3
Megan M Shuey
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 7
Stephen B Ellis
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 27
Shefali S Verma
University of Pennsylvania
Career Start Year 2013
Number of shared co-authors 34
Eric Farber-Eger
Vanderbilt University Medical Center
Career Start Year 2013
Number of shared co-authors 20
Omri Gottesman
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 37
Lisa Bastarache
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 39
Cyrine E Haidar
St. Jude Children's Research Hospital
Career Start Year 2009
Number of shared co-authors 17
Nathan E Wineinger
Scripps Research Translational Institute, The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 1
Quinn S Wells
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 36
James S Floyd
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 13
Adam S Gordon
Northwestern University Feinberg School of Medicine.
Career Start Year 2008
Number of shared co-authors 35
QiPing Feng
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 25
Terrie Kitchner
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Career Start Year 2007
Number of shared co-authors 34
Donald M Smith
Georgetown University Medical Center
Career Start Year 2006
Number of shared co-authors 16
Christian M Shaffer
Vanderbilt University
Career Start Year 2004
Number of shared co-authors 41
Wei-Qi Wei
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 37
Li Gong
Stanford University
Career Start Year 2004
Number of shared co-authors 22
Laura J Rasmussen-Torvik
Northwestern University, Center for Genetic Medicine
Career Start Year 2003
Number of shared co-authors 43
Alex S F Doney
University of Dundee. Ninewells Hospital
Career Start Year 2002
Number of shared co-authors 30
Andrew D Johnson
and Blood Institute
Career Start Year 2001
Number of shared co-authors 32
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 7
Linnea M Baudhuin
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 5
Deepak Voora
Durham VA Healthcare System and Duke University
Career Start Year 1998
Number of shared co-authors 16
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 4
Michelle Whirl-Carrillo
Stanford University
Career Start Year 1995
Number of shared co-authors 22
Jonathan D Mosley
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 30
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 45
Geoffrey S Ginsburg
National Institutes of Health
Career Start Year 1981
Number of shared co-authors 19

Collaborators

Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 19
Rhonda M Cooper-DeHoff
College of Medicine, University of Florida
Co-authored papers 13
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 12
Caitrin W McDonough
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 9
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 8
Stephen T Turner
Mayo Clinic
Co-authored papers 7
Amber L Beitelshees
University of Maryland School of Medicine
Co-authored papers 6
Eric Boerwinkle
Baylor College of Medicine
Co-authored papers 5
Sony Tuteja
University of Pennsylvania Perelman School of Medicine
Co-authored papers 4
Marc B Rosenman
Northwestern University Feinberg School of Medicine
Co-authored papers 4
Nita A Limdi
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 4
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers 4
Sara L Van Driest
National Institutes of Health
Co-authored papers 3
Stuart A Scott
Stanford University
Co-authored papers 3
Kent R Bailey
Mayo Clinic
Co-authored papers 3
Michiaki Kubo
Co-authored papers 2
James J Cimino
Informatics Institute, University of Alabama
Co-authored papers 2
Heidi E Steiner
Data Science Institute, University of Arizona
Co-authored papers 2
Gloria Lipori
University of Florida Health
Co-authored papers 2
Nicola Glorioso
Co-authored papers 2
Dana C Crawford
Cleveland Institute for Computational Biology, Case Western Reserve University
Co-authored papers 2
Toshihiro Tanaka
Bioresourse Research Center, Tokyo Medical and Dental University (TMDU)
Co-authored papers 2
Jason H Karnes
Vanderbilt University Medical Center
Co-authored papers 2
Atsushi Takahashi
Co-authored papers 2
Helen R Warren
Co-authored papers 2
Yaping Shi
Vanderbilt University Medical Center
Co-authored papers 2
James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 2
Patricia B Munroe
Co-authored papers 2
Elliot M Fielstein
Vanderbilt University Medical Center, Vanderbilt University.
Co-authored papers 2
Jonathan S Schildcrout
Vanderbilt University Medical Center.
Co-authored papers 2
Release 1.2